Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124887492 | 12488749 | 2 | F | 2016 | 20160819 | 20160622 | 20160824 | EXP | US-PFIZER INC-2016309499 | PFIZER | 22.00 | YR | F | Y | 70.00000 | KG | 20160824 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124887492 | 12488749 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, 3X/DAY | 20235 | 600 | MG | CAPSULE, HARD | TID | |||||||
| 124887492 | 12488749 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, 3X/DAY | 20235 | 600 | MG | CAPSULE, HARD | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124887492 | 12488749 | 1 | Migraine |
| 124887492 | 12488749 | 2 | Muscle twitching |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124887492 | 12488749 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124887492 | 12488749 | Drug detoxification | |
| 124887492 | 12488749 | Dyskinesia | |
| 124887492 | 12488749 | Generalised tonic-clonic seizure | |
| 124887492 | 12488749 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124887492 | 12488749 | 1 | 20160101 | 201605 | 0 |